1
|
Pees C, Laccone F, Radakovic S, Michel-Behnke I, Zimpfer D. A Rare Case of Autosomal Recessive Cutis Laxa Type Ib in a Young Girl with Arterial Aneurysms and Successful Valve Sparing Root and Aortic Arch Replacement. Thorac Cardiovasc Surg 2022. [DOI: 10.1055/s-0042-1742962] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- C. Pees
- Institute of Pediatric Cardiology, Medical University of Vienna, Vienna, Austria
| | - F. Laccone
- Institute of Medical Genetics, Medical University of Vienna, Vienna, Austria
| | - S. Radakovic
- Institute of Dermatology, Medical University of Vienna, Vienna, Austria
| | - I. Michel-Behnke
- Institute of Pediatric Cardiology, Medical University of Vienna, Vienna, Austria
| | - D. Zimpfer
- Institute of Cardiovascular Surgery, Medical University of Vienna, Vienna, Austria
| |
Collapse
|
2
|
Müller C, Tanew A, Laml-Wallner G, Radakovic S. Successful treatment of calcinosis cutis with a topical sodium thiosulphate preparation containing 20% zinc oxide in a patient with sclerotic graft-versus-host disease. J Eur Acad Dermatol Venereol 2021; 36:e39-e41. [PMID: 34416055 DOI: 10.1111/jdv.17610] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2021] [Accepted: 08/12/2021] [Indexed: 11/27/2022]
Affiliation(s)
- C Müller
- Department of Dermatology, Medical University of Vienna, Vienna, Austria
| | - A Tanew
- Privat practice, Vienna, Austria
| | - G Laml-Wallner
- Pharmacy Department, Vienna General Hospital, Medical University Campus, Vienna, Austria
| | - S Radakovic
- Department of Dermatology, Medical University of Vienna, Vienna, Austria
| |
Collapse
|
3
|
Schremser V, Sinz C, Tanew A, Radakovic S. Myriad of pigmented lesions in a patient with Costello syndrome. J Eur Acad Dermatol Venereol 2021; 35:e514-e516. [PMID: 33783899 DOI: 10.1111/jdv.17254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- V Schremser
- Department of Dermatology, Medical University of Vienna, Vienna, Austria
| | - C Sinz
- Department of Dermatology, Medical University of Vienna, Vienna, Austria
| | - A Tanew
- Department of Dermatology, Medical University of Vienna, Vienna, Austria
| | - S Radakovic
- Department of Dermatology, Medical University of Vienna, Vienna, Austria
| |
Collapse
|
4
|
Aichelburg MC, Pinkowicz A, Holzer G, Radakovic S, Sator PG, Tanew A. Short- and long-term efficacy of fumaric acid esters or acitretin in combination with a 12-week course of PUVA in the treatment of palmoplantar pustulosis: results from a prospective randomized trial. J Eur Acad Dermatol Venereol 2020; 35:e198-e200. [PMID: 32869392 DOI: 10.1111/jdv.16909] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- M C Aichelburg
- Department of Dermatology, Medical University of Vienna, Vienna, Austria.,Department of Dermatology, Sozialmedizinisches Zentrum Ost-Donauspital, Vienna, Austria
| | - A Pinkowicz
- Department of Dermatology, Medical University of Vienna, Vienna, Austria
| | - G Holzer
- Department of Dermatology, Medical University of Vienna, Vienna, Austria.,Department of Dermatology, Sozialmedizinisches Zentrum Ost-Donauspital, Vienna, Austria
| | - S Radakovic
- Department of Dermatology, Medical University of Vienna, Vienna, Austria
| | - P-G Sator
- Department of Dermatology, Krankenhaus Hietzing, Vienna, Austria
| | - A Tanew
- Department of Dermatology, Medical University of Vienna, Vienna, Austria
| |
Collapse
|
5
|
Holzer G, Hoke M, Sabeti-Sandor S, Perkmann T, Rauscher A, Strassegger B, Radakovic S, Tanew A. Disparate effects of adalimumab and fumaric acid esters on cardiovascular risk factors in psoriasis patients: results from a prospective, randomized, observer-blinded head-to-head trial. J Eur Acad Dermatol Venereol 2020; 35:441-449. [PMID: 32426884 DOI: 10.1111/jdv.16635] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2020] [Accepted: 04/23/2020] [Indexed: 11/28/2022]
Abstract
BACKGROUND The effect of adalimumab and fumaric acid esters (FAE) on the cardiovascular risk associated with psoriasis has only been investigated scarcely in randomized controlled studies. OBJECTIVE The aim of this prospective, randomized controlled head-to-head trial was to compare the influence of adalimumab and FAE on cardiovascular disease markers in psoriasis patients. METHODS Sixty-five patients with moderate to severe plaque psoriasis were randomly assigned to adalimumab or FAE treatment for 6 months. Cardiovascular haemodynamic parameters [flow-mediated dilation (FMD), nitro-glycerine mediated dilation (NMD) and carotid intima-media thickness (CIMT), blood pressure] were assessed at baseline (v0) and after 6 months (v6). Cutaneous disease severity, inflammatory and lipid cardiovascular risk markers were analysed at baseline(v0), after 3 (v3) and 6 months (v6). RESULTS After 6 months of treatment FMD in the adalimumab group increased significantly [v0 5.9% (6.4% SD), v6 8.0% (4.8% SD), P = 0.048) but not in the FAE group. (v0 7.0% (4.1% SD), v6 8.4% (6.1% SD), P = 0.753]. This was paralleled by a significant decrease of high sensitive C-reactive protein (hsCRP) in the adalimumab group in comparison to the FAE group (v0: 0.39 mg/dL (0.38 SD), v6: 0.39 mg/dL (0.48 SD), P = 0.043). No significant changes were observed in any other haemodynamic parameters. FAE, however, additionally decreased total cholesterol (P = 0.046) and apolipoprotein B (P = 0.041) levels compared to adalimumab. Mean Psoriasis Area and Severity Index (psoriasis area severity score) reduction was greater but not significant (P = 0.116) under adalimumab treatment compared to FAE treatment [-71.1% (29.9 SD) vs. -54.6% (45.7%)]. CONCLUSION In our study, both treatments were documented to exert effects on the cardiovascular system. While adalimumab showed anti-inflammatory effects and improved FMD, FAE interacted favourably with the cholesterol metabolism.
Collapse
Affiliation(s)
- G Holzer
- Department of Dermatology, Medical University of Vienna, Austria.,Department of Dermatology, Donauspital, SMZ Ost, Vienna, Austria.,Medical Research Society Vienna DC, Vienna, Austria
| | - M Hoke
- Department of Internal Medicine II, Division of Angiology, Medical University of Vienna, Vienna, Austria
| | - S Sabeti-Sandor
- Department of Internal Medicine II, Division of Angiology, Medical University of Vienna, Vienna, Austria
| | - T Perkmann
- Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
| | - A Rauscher
- Department of Dermatology, Medical University of Vienna, Austria
| | - B Strassegger
- Department of Dermatology, Donauspital, SMZ Ost, Vienna, Austria
| | - S Radakovic
- Department of Dermatology, Medical University of Vienna, Austria
| | - A Tanew
- Department of Dermatology, Medical University of Vienna, Austria
| |
Collapse
|
6
|
Radakovic S, Dangl M, Tanew A. 5-Aminolevulinic acid patch (Alacare) photodynamic therapy for actinic cheilitis: data from a prospective 12-month follow-up study on 21 patients. J Eur Acad Dermatol Venereol 2020; 34:2011-2015. [PMID: 31999856 PMCID: PMC7496675 DOI: 10.1111/jdv.16247] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2019] [Accepted: 01/08/2020] [Indexed: 11/29/2022]
Abstract
Background Actinic cheilitis (AC) is a variant of actinic keratosis (AK) affecting the lips and caused by chronic ultraviolet exposure. Objective Alacare is a self‐adhesive, skin‐coloured 5‐aminolaevulinic acid patch that has been developed for use in photodynamic therapy (PDT) of mild‐to‐moderate AK. Based on promising preliminary results in the treatment of AC with Alacare patch PDT, we decided to extend our previous investigation to gain more data on the efficacy, tolerability, safety and cosmetic outcome of Alacare patch PDT for AC. Methods Twenty‐one patients with a clinical diagnosis of mild‐to‐moderate AC were included in the study and subjected to one single session of PDT. After occlusion with the Alacare patch for 4 h, the AC lesions were illuminated for 10 min with red light at a dose of 37 J/cm2. All patients received local anaesthesia prior to illumination. Additionally, all lesions were cooled during PDT with a cold air blower. PDT‐induced pain and skin phototoxicity were monitored during and up to 7 days after PDT. Clinical assessment of efficacy, cosmetic outcome and global patient satisfaction was performed at 3, 6 and 12 months after treatment. Results Nineteen patients completed the study. Three months after PDT, 17 patients (89.5%) had achieved complete remission. Of these, one patient presented with recurrence of AC at the 6‐month follow‐up, whereas all other patients remained in remission until the end of the observation period. The complete clinical cure rate at 1 year after a single Alacare patch PDT thus was 84.2%. Pain during illumination and the phototoxic skin reaction were in general mild to moderate. The cosmetic outcome was excellent. Conclusion The present prospective study on Alacare patch PDT for AC confirms its high clinical efficacy, good tolerability and favourable cosmetic effects. Alacare patch PDT should be considered as a valid treatment option for patients with AC.
Collapse
Affiliation(s)
- S Radakovic
- Department of Dermatology, Medical University of Vienna, Vienna, Austria
| | - M Dangl
- Landesklinikum Gmünd, Gmünd, Austria
| | - A Tanew
- Department of Dermatology, Medical University of Vienna, Vienna, Austria
| |
Collapse
|
7
|
Weber B, Marculescu R, Radakovic S, Tanew A. Serum levels of folate, 25-hydroxyvitamin D3 and cobalamin during UVB phototherapy: findings in a large prospective trial. J Eur Acad Dermatol Venereol 2019; 34:385-391. [PMID: 31494977 PMCID: PMC7027503 DOI: 10.1111/jdv.15941] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2019] [Accepted: 08/21/2019] [Indexed: 11/29/2022]
Abstract
Background Narrowband UVB phototherapy (NB‐UVB) is a mainstay in the treatment of numerous inflammatory dermatoses. Whereas, a wealth of studies has shown that NB‐UVB treatment increases 25‐hydroxyvitamin D3 (25(OH)D) levels, only sparse and controversial data exist on its effect on serum folate and cobalamin. Objectives To determine whether exposure to NB‐UVB alters serum folate or cobalamin levels. Methods A single‐centre, prospective, open observational study on 101 patients subjected to NB‐UVB phototherapy between late fall and early spring. Serum folate, 25(OH)D and cobalamin levels were measured after 0, 12, 24 and 36 NB‐UVB exposures. Results After 12 NB‐UVB exposures a significant decrease of mean serum folate (−1.0 nmol/L; P = 0.03) and cobalamin (−14.5 pmol/L, P = 0.03) levels was observed whereas serum levels of 25(OH)D showed a significant increase (35.4 nmol/L, P < 0.0001). Conclusions A standard course of NB‐UVB induces a small but significant decrease of serum folate and cobalamin levels.
Collapse
Affiliation(s)
- B Weber
- Department of Dermatology, Medical University of Vienna, Vienna, Austria
| | - R Marculescu
- Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
| | - S Radakovic
- Department of Dermatology, Medical University of Vienna, Vienna, Austria
| | - A Tanew
- Department of Dermatology, Medical University of Vienna, Vienna, Austria
| |
Collapse
|
8
|
Dorfer S, Haas S, Birner P, Kirnbauer R, Petzelbauer P, Radakovic S, Pehamberger H, Harpain L, Handisurya A. 579 High-risk human papillomavirus infection in Bowen’s disease and Squamous Cell Carcinomas of the hands. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.07.776] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
9
|
Trattner H, Blüml S, Steiner I, Plut U, Radakovic S, Tanew A. Quality of life and comorbidities in palmoplantar pustulosis - a cross-sectional study on 102 patients. J Eur Acad Dermatol Venereol 2017; 31:1681-1685. [DOI: 10.1111/jdv.14187] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2016] [Accepted: 02/06/2017] [Indexed: 01/08/2023]
Affiliation(s)
- H. Trattner
- Department of Dermatology; Medical University of Vienna; Vienna Austria
| | - S. Blüml
- Department of Rheumatology; Medical University of Vienna; Vienna Austria
| | - I. Steiner
- Center for Medical Statistics, Informatics and Intelligent Systems; Section for Medical Statistics; Medical University of Vienna; Vienna Austria
| | - U. Plut
- Department of Dermatology; Medical University of Vienna; Vienna Austria
| | - S. Radakovic
- Department of Dermatology; Medical University of Vienna; Vienna Austria
| | - A. Tanew
- Department of Dermatology; Medical University of Vienna; Vienna Austria
| |
Collapse
|
10
|
Holzer G, Pinkowicz A, Radakovic S, Schmidt J, Tanew A. Randomized controlled trial comparing 35% trichloroacetic acid peel and 5-aminolaevulinic acid photodynamic therapy for treating multiple actinic keratosis. Br J Dermatol 2017; 176:1155-1161. [DOI: 10.1111/bjd.15272] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/07/2016] [Indexed: 12/17/2022]
Affiliation(s)
- G. Holzer
- Department of Dermatology; Medical University of Vienna; Vienna, SMZ Ost, 122, Langobardenstrasse 1220 Vienna Austria
- Department of Dermatology; Donauspital; SMZ Ost Vienna Vienna Austria
- Medical Research Society Vienna DC; Vienna Austria
| | - A. Pinkowicz
- Department of Dermatology; Medical University of Vienna; Vienna, SMZ Ost, 122, Langobardenstrasse 1220 Vienna Austria
| | - S. Radakovic
- Department of Dermatology; Medical University of Vienna; Vienna, SMZ Ost, 122, Langobardenstrasse 1220 Vienna Austria
| | - J.B. Schmidt
- Department of Dermatology; Medical University of Vienna; Vienna, SMZ Ost, 122, Langobardenstrasse 1220 Vienna Austria
| | - A. Tanew
- Department of Dermatology; Medical University of Vienna; Vienna, SMZ Ost, 122, Langobardenstrasse 1220 Vienna Austria
| |
Collapse
|
11
|
Radakovic S, Breier-Maly J, Konschitzky R, Kittler H, Sator P, Hoenigsmann H, Tanew A. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial. J Eur Acad Dermatol Venereol 2009; 23:951-3. [DOI: 10.1111/j.1468-3083.2009.03138.x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
12
|
Sator PG, Sator MO, Schmidt JB, Nahavandi H, Radakovic S, Huber JC, Hönigsmann H. A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women. Climacteric 2007; 10:320-34. [PMID: 17653959 DOI: 10.1080/13697130701444073] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
BACKGROUND There is mounting evidence that menopause affects some functions of the skin. Hormone replacement therapy (HRT) appears to limit some of the climacteric aspects of cutaneous aging. OBJECTIVE In the light of a growing interest in the endocrinological influence of skin, we performed a study evaluating the effects of HRT on skin aging in postmenopausal women. METHODS Forty non-hysterectomized, postmenopausal women were included in this prospective, randomized, double-blind, placebo-controlled study on the influence of oral sequential treatment with a combination of 2 mg 17beta-estradiol/10 mg dydrogesterone (Femoston) for seven 28-day cycles. Skin elasticity, skin surface lipids, skin hydration and skin thickness were measured by non-invasive methods, and both adverse-event profile and clinical-dermatological status were evaluated. RESULTS After 7 months of HRT, skin elasticity increased significantly at the right ramus of the mandible, while skin hydration tended to improve significantly at the right upper arm (inner side); skin thickness improved significantly but skin surface lipids did not. Absolute effects did not differ significantly between HRT and placebo patients. A dermatological evaluation was largely consistent with measurement results. Safety and tolerability of HRT were positive. CONCLUSION The results showed improvements in the parameters involved in skin aging in the HRT group as compared to baseline. While skin aging is no indication for systemic hormone supplementation, a positive effect on aging skin can be observed.
Collapse
Affiliation(s)
- P-G Sator
- Division of Special and Environmental Dermatology, Department of Dermatology, Medical University of Vienna, General Hospital, Vienna, Austria
| | | | | | | | | | | | | |
Collapse
|